Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Clinical trial NCT07689240 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07689240
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-02-10
- Primary completion
- 2032-01-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.